ARYA Sciences Acquisition Corp IV Stock price

Equities

ARYD

KYG316591083

Investment Holding Companies

Market Closed - Nasdaq 04:30:00 2024-03-28 pm EDT 5-day change 1st Jan Change
11.23 USD -0.27% Intraday chart for ARYA Sciences Acquisition Corp IV -0.27% +3.03%
Sales 2021 - Sales 2022 - Capitalization 194M
Net income 2021 -6M Net income 2022 1M EV / Sales 2021 -
Net cash position 2021 0.5 Net Debt 2022 0.03 EV / Sales 2022 -
P/E ratio 2021
-25 x
P/E ratio 2022
182 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 48.97%
More Fundamentals * Assessed data
Dynamic Chart
ARYA Sciences Acquisition Corp IV announced that it has received $1 million in funding from ARYA Sciences Holdings IV CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
ARYA Sciences Acquisition Corp IV announced that it has received $0.9 million in funding from ARYA Sciences Holdings IV CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
ARYA Sciences Acquisition Corp IV announced that it has received $0.14 million in funding from ARYA Sciences Holdings IV CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Full Year Ended December 31, 2022 CI
ARYA Sciences Acquisition Corp IV Auditor Raises 'Going Concern' Doubt CI
ARYA Sciences Acquisition Corp IV announced that it expects to receive $1.68 million in funding from ARYA Sciences Holdings IV CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
ARYA Sciences Acquisition Corp IV announced that it has received $0.12 million in funding from ARYA Sciences Holdings IV CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Full Year Ended December 31, 2021 CI
ARYA Sciences Acquisition Corp IV Auditor Raises 'Going Concern' Doubt CI
More news
1 day-0.27%
1 week-0.27%
Current month-0.09%
1 month+0.36%
3 months+2.93%
6 months+3.98%
Current year+3.03%
More quotes
1 week
11.23
Extreme 11.23
11.27
1 month
11.19
Extreme 11.19
11.27
Current year
10.91
Extreme 10.91
11.27
1 year
10.32
Extreme 10.32
11.27
3 years
9.70
Extreme 9.7
11.45
5 years
9.70
Extreme 9.7
12.38
10 years
9.70
Extreme 9.7
12.38
More quotes
Managers TitleAgeSince
Founder 45 20-08-23
Founder 40 20-12-31
Founder 43 20-08-23
Members of the board TitleAgeSince
Director/Board Member 53 21-02-24
Founder 68 20-08-23
Founder 43 20-08-23
More insiders
Date Price Change Volume
24-03-28 11.23 -0.27% 410
24-03-25 11.26 +0.27% 15,572
24-03-22 11.23 -0.09% 171,437
24-03-21 11.24 -0.18% 44,810
24-03-20 11.26 -0.09% 2,499

Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT

More quotes
ARYA Sciences Acquisition Corp IV is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The Company is focused on healthcare or healthcare related industries. The Company has no operations and has not generated revenues.
More about the company
  1. Stock
  2. Equities
  3. Stock ARYA Sciences Acquisition Corp IV - Nasdaq